PER 1.25% 7.9¢ percheron therapeutics limited

Ann: US FDA Type C Meeting for ATL1102 in DMD, page-29

  1. 17,370 Posts.
    lightbulb Created with Sketch. 1340
    Disagree. Clinical factors you mention re: Safety are all Phase 1 protocols

    You would expect them to all be ok given we are about to go to P2B

    Nothing until late May

    Today's volume is also telling you the same story - only 1m traded. Only retail nuff nuffs buying, not the HNW's or Insto's backed by the brokerage houses that have valuations on it
    Last edited by Wise_One: 23/04/21
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.9¢
Change
-0.001(1.25%)
Mkt cap ! $71.22M
Open High Low Value Volume
7.9¢ 7.9¢ 7.9¢ $7.9K 100K

Buyers (Bids)

No. Vol. Price($)
3 69319 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 60863 2
View Market Depth
Last trade - 10.32am 16/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.